Salkind Gene's Form 4 filing
Upexi, Inc. (UPXI) · filed Apr 25, 2025
- Accession no.
- 0001477932-25-002979
- Filed
- Apr 25, 2025
- Trade date
- Jan 17-Apr 17, 2025
- Filing delay
- 98 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 2 derivative transactions. Open-market purchases total $550.0K. It was filed 98 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Salkind GeneCIK 0001592481 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2025 | Common Stock | PPurchaseAcquired | +241,229 | $2.28 | +$550,002.12 | 365,127 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | Common | AGrant or awardAcquired | +25,000 | $0.00 | $0 | 25,000 | Direct | |
| Apr 17, 2025 | Common | AGrant or awardAcquired | +35,000 | $0.00 | $0 | 35,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.